Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Acute pelvic pain in women: rule out pregnancy, look for pelvic inflammatory disease

Gynaecology and obstetrics · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In 39 public hospitals in Île-de-France (AP-HP), 901 episodes of upper genital tract infection in 880 women aged 18 to 45 between July 2017 and December 2019, Chlamydia trachomatis being detected in 9.9% of them [1]. No recent national incidence found.

First tests (suspected pelvic inflammatory disease)

Laboratory tests

Speculum sample (endocervix; vaginal failing that)

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Follow-up after pelvic inflammatory disease

3 to 6 months after treatment

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (11)
  1. Development of an algorithm to identify pelvic inflammatory diseases using regional electronic hospital records: first step to assess the burden of Chlamydia trachomatis infections. BMJ Open 2026;16:e111779.
  2. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108-14.
  3. Collège national des gynécologues et obstétriciens français (CNGOF), Société de pathologie infectieuse de langue française (SPILF). Les infections génitales hautes : mise à jour des recommandations pour la pratique clinique (texte court). Gynecol Obstet Fertil Senol. 2019;47(5):398-403. Version anglaise : Brun JL, Castan B, de Barbeyrac B, et al. Pelvic inflammatory diseases: updated French guidelines. J Gynecol Obstet Hum Reprod. 2020;49(5):101714.
  4. Haute Autorité de santé, Conseil national du sida et des hépatites virales, ANRS-MIE. Traitement curatif des personnes infectées par Mycoplasma genitalium. Recommandation de bonne pratique, avril 2025.
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 5202 (prélèvement génital féminin), 5301 et 5304 (amplification génique Chlamydia, gonocoque, Mycoplasma genitalium), 1307 (sérologie Chlamydia).
  6. Ross J, Cole M, Evans C, Lyons D, Dean G, Cousins D. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update). British Association for Sexual Health and HIV.
  7. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG). Richtlijn Pelvic Inflammatory Disease, modules « Microbiologisch onderzoek » et « Klinische criteria », publiée le 16 avril 2020.
  8. ASHM. Australian STI Management Guidelines for Use in Primary Care : Pelvic Inflammatory Diseases (PID), consulté le 30 octobre 2026.
  9. Frasca DJ, Jarrio CE, Perdue J. Evaluation of Acute Pelvic Pain in Women. Am Fam Physician. 2023;108(2):175-180.
  10. Haute Autorité de santé, Conseil national du sida et des hépatites virales, ANRS-MIE. Traitement curatif des personnes infectées par Chlamydia trachomatis. Recommandation de bonne pratique, avril 2025.
  11. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187 (partie « Pelvic Inflammatory Disease »).